Akers Biosciences Announces Conference Call to Discuss Fiscal Year 2017 Earnings
15 mars 2018 13h11 HE
|
Akers Biosciences Inc
THOROFARE, N.J, March 15, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will...
Akers Biosciences Announces Closing of $6,900,000 Public Offering
21 déc. 2017 16h58 HE
|
Akers Biosciences Inc
THOROFARE, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or “Akers Bio”), a developer of rapid health information technologies, today...
Akers Biosciences Prices $6,000,000 Public Offering
18 déc. 2017 22h01 HE
|
Akers Biosciences Inc
THOROFARE, N.J, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or “Akers Bio”), a developer of rapid health information technologies, today...
Akers Biosciences Secures Further Intellectual Property Protection for Akers Wellness Line
08 déc. 2017 10h31 HE
|
Akers Biosciences Inc
THOROFARE, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Biosciences Announces Q3 2017 Earnings
15 nov. 2017 07h00 HE
|
Akers Biosciences Inc
Revenues up 10% as Breathalyzers and Cholesterol Tests Begin to Contribute THOROFARE, N.J, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L),...
Akers Biosciences’ UK Distributor Secures New Channel for Rapid Alcohol Breathalyzer
14 nov. 2017 07h00 HE
|
Akers Biosciences Inc
Distributor Accutest Now Selling Through Today’s Group THOROFARE, N.J, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a...
Akers Biosciences Announces Conference Call to Discuss Q3 2017 Earnings
13 nov. 2017 09h00 HE
|
Akers Biosciences Inc
THOROFARE, N.J., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will...
Akers Biosciences to Present at Disruptive Growth & Healthcare Conference
08 févr. 2016 12h18 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), (“Akers Bio” or the "Company"), a developer of cutting edge technologies that deliver rapid...
Akers Biosciences Updates on Joint Venture in China
01 déc. 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a developer and supplier of screening and testing technologies...
Akers Biosciences to Present at 8th Annual LD Micro Investor Conference
30 nov. 2015 07h00 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a developer of cutting edge technologies that deliver rapid health...